Debate: Preventive coronary intervention for vulnerable plaque. The interventional cardiologist s approach
- 18 November 2024
- journal article
- research article
- Published by Instituto Mexicano del Seguro Social in REC: Interventional Cardiology (English Edition)
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trialThe Lancet, 2024
- Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 YearsJACC, 2023
- Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in SpainAtherosclerosis, 2023
- Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial InfarctionJAMA, 2022
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceEuropean Heart Journal, 2021
- Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic PlaqueJACC, 2020
- Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registryEuropean Heart Journal, 2019
- Impact of Statins on Serial Coronary Calcification During Atheroma Progression and RegressionJACC, 2015
- Mechanisms of Plaque Formation and RuptureCirculation Research, 2014
- Improving the Quality of Percutaneous Revascularisation in Patients with Multivessel Disease in Australia: Cost-Effectiveness, Public Health Implications, and Budget Impact of FFR-Guided PCIHeart, Lung and Circulation, 2014